Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-10-25

Clinical Trial Update: Efficacy Maxinom® And Maxitrol® in Reducing The Signs And Symptoms Of Acute Bacterial Conjunctivitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy of Maxinom and Maxitrol in reducing signs and symptoms of acute bacterial conjunctivitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MAXITROL (Neomycin sulfate, polymyxin B sulfate and dexamethasone; neomycin and polymyxin B sulfates and dexamethasone)
  • Maxinom

Snippet

Sponsor: Azidus Brasil | Conditions: Bacterial Conjunctivitis, Acute | Phase 3 | Status: UNKNOWN